Accelrys Announces Date of First Quarter, Fiscal 2005 Financial Results and Conference Call
SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- Accelrys, Inc. (Nasdaq: ACCL) today announced that it plans to release its financial results for the quarter ended June 30, 2004 after the NASDAQ Market closes on Thursday July 29, 2004. The company will conduct a conference call and an audio webcast at 5:00 p.m. EDT on the same day. Mark Emkjer, President, and CEO will host the call. Forward-looking and other material information may be discussed on this conference call. Conference call numbers are as follows: Domestic callers: 1-800-299-9086 International callers: 1-617-786-2903 Passcode: 79632078 Webcast information: http://www.accelrys.com/ir/meetings.html A replay of the conference call, which can be accessed by dialing toll-free 1-888-286-8010, and outside the U.S. 1-617-801-6888, will be available for 2 weeks. The access code for the replay is 76642531. About Accelrys, Inc. Accelrys, Inc. (Nasdaq: ACCL) is the parent of Accelrys Software Inc., a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists and materials scientists, including nanotechnology researchers for product design as well as drug discovery and development. Accelrys technology and services are designed to meet the needs of today's leading research organizations. The company is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://www.accelrys.com/. When used anywhere in this document, the words expects, believes, anticipates, estimates, and similar expressions are intended to identify forward-looking statements. Forward-looking statements herein may include statements addressing future financial and operating results of Accelrys. Accelrys has based these forward-looking statements on its current expectations about future events. Such statements are subject to risks and uncertainties including, but not limited to, the successful implementation of Accelrys' strategic plans, the acceptance of new products, the obsolescence of existing products, the resolution of existing and potential future patent issues, additional competition, changes in economic conditions, and other risks described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and subsequent reports on Form 10-Q. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any undertaking to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT: John Hanlon, CFO, +1-858-799-5000, or Ian Clements, Director, Corporate Communications, +1-858-799-5440, email@example.com, both of Accelrys, Inc.
SOURCE Accelrys, Inc.
More by this Source
New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug Discovery
Apr 17, 2014, 08:00 ET
Accelrys® Speeds Life Science Decisions with Next-Generation Insight®
Apr 10, 2014, 08:00 ET
Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014
Mar 27, 2014, 17:21 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.